{"id":177146,"date":"2013-06-11T00:00:00","date_gmt":"2013-06-10T22:00:00","guid":{"rendered":"https:\/\/www.bcfi.be\/stopzetting-van-de-commercialisering-van-elthyrone-levothyroxine-vanaf-1-november-2013\/"},"modified":"2026-04-02T19:11:34","modified_gmt":"2026-04-02T17:11:34","slug":"stopzetting-van-de-commercialisering-van-elthyrone-levothyroxine-vanaf-1-november-2013","status":"publish","type":"post","link":"https:\/\/h.cbip.be\/nl\/stopzetting-van-de-commercialisering-van-elthyrone-levothyroxine-vanaf-1-november-2013\/","title":{"rendered":"Stopzetting van de commercialisering van Elthyrone\u00ae (levothyroxine) vanaf 1 november 2013"},"content":{"rendered":"<div class='tekst'>\n<p>\u00a0<\/p>\n<p>De firma meldt dat de commercialisering van Elthyrone\u00ae (levothyroxine) definitief wordt stopgezet vanaf 1 november 2013. Twee andere specialiteiten op basis van levothyroxine&#x002C; Euthyrox\u00ae en L-Thyroxine\u00ae&#x002C; blijven beschikbaar.<\/p>\n<p>Het is aanbevolen geen nieuwe behandelingen meer op te starten met Elthyrone\u00ae. Pati\u00ebnten op Elthyrone\u00ae kunnen worden overgeschakeld op Euthyrox\u00ae of L-Thyroxine\u00ae aan eenzelfde dosis. Gezien de nauwe therapeutisch-toxische marge van thyro\u00efdhormoon behoort levothyroxine in het kader van het voorschrijven op stofnaam tot de geneesmiddelengroep \u201cno switch\u201d en \u00a0mag hier niet zomaar gesubstitueerd worden. Bij de overschakeling is extra opvolging noodzakelijk [zie daaromtrent ook Folia april 2012 (<a href='https:\/\/www.bcfi.be\/Folia\/2012\/F39N04B.cfm'>https:\/\/www.bcfi.be\/Folia\/2012\/F39N04B.cfm<\/a>)]. Na de overschakeling moet men waakzaam zijn voor heroptreden van de symptomen en is controle van de TSH-concentraties of&#x002C; bij secundaire hypothyreo\u00efdie van hypofysaire of hypothalamische oorsprong&#x002C; van vrij T<sub>4&#x002C; <\/sub>noodzakelijk.<\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>\u00a0 De firma meldt dat de commercialisering van Elthyrone\u00ae (levothyroxine)  [&#8230;]<\/p>\n","protected":false},"author":9,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[43,183],"tags":[20213,20224],"class_list":["post-177146","post","type-post","status-publish","format-standard","hentry","category-nieuw","category-2013-nl","tag-import_tags","tag-import_tags-nl"],"_links":{"self":[{"href":"https:\/\/h.cbip.be\/nl\/wp-json\/wp\/v2\/posts\/177146","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/h.cbip.be\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/h.cbip.be\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/h.cbip.be\/nl\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/h.cbip.be\/nl\/wp-json\/wp\/v2\/comments?post=177146"}],"version-history":[{"count":1,"href":"https:\/\/h.cbip.be\/nl\/wp-json\/wp\/v2\/posts\/177146\/revisions"}],"predecessor-version":[{"id":179720,"href":"https:\/\/h.cbip.be\/nl\/wp-json\/wp\/v2\/posts\/177146\/revisions\/179720"}],"wp:attachment":[{"href":"https:\/\/h.cbip.be\/nl\/wp-json\/wp\/v2\/media?parent=177146"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/h.cbip.be\/nl\/wp-json\/wp\/v2\/categories?post=177146"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/h.cbip.be\/nl\/wp-json\/wp\/v2\/tags?post=177146"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}